Showing results (291-300 of 379) with videos related to
Sort By:
Pageof 38
Intensive Care Medicine|October 8, 2024
Environmental sustainability in intensive care: the path forward. An ESICM Green PaperJan J De Waele, Nicole Hunfeld, Heather Baid, et al.Med (New York, N.Y.)|September 22, 2023
A multi-country analysis of COVID-19 hospitalizations by vaccination statusBronner P Gonçalves, Waasila Jassat, Joaquín Baruch, et al.Transplantation Direct|June 3, 2017
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for MortalityMatteo Bassetti, Maddalena Peghin, Alessia Carnelutti, et al.Intensive Care Medicine|April 3, 2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martin-Loeches, Antoni Torres, Blin Nagavci, et al.Shock (Augusta, Ga.)|June 5, 2020
Aminoglycosides in Immunocompromised Critically Ill Patients With Bacterial Pneumonia and Septic Shock: A Post-Hoc Analysis of a Prospective Multicenter Multinational CohortRené Lopez, Jordi Rello, Fabio Silvio Taccone, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 9, 2015
Chromogranin A levels and mortality in patients with severe sepsisChih-Hsin Hsu, Luis F Reyes, Carlos J Orihuela, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 1, 2013
IgM levels in plasma predict outcome in severe pandemic influenzaMar Justel, Lorenzo Socias, Raquel Almansa, et al.Journal of Critical Care|February 26, 2022
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19Luis Felipe Reyes, Alejandro Rodriguez, Alirio Bastidas, et al.Intensive Care Medicine|September 25, 2025
Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort studyPeter Schellongowski, Michael Darmon, Philipp Eller, et al.Annals of Translational Medicine|July 16, 2021
Practice of adjunctive treatments in critically ill COVID-19 patients-rational for the multicenter observational PRoAcT-COVID study in The NetherlandsChristel M A Valk, Pien Swart, Leonoor S Boers, et al.Pageof 38